DDR2-mutations are also occurring in approximately 1.5% of LACs (http://cancer.sanger.ac.uk/cosmic), though their frequency was reported increased to 16% in EGFRM+ NSCLC [118]. This evidence concerns the gene DDR2 and non-small cell lung carcinoma.